Ignite Creation Date:
2024-05-05 @ 11:33 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00070278
Status:
UNKNOWN
Last Update Posted:
2013-08-07
First Post:
2003-10-03
Brief Title:
Neoadjuvant Epirubicin Cyclophosphamide and Paclitaxel With or Without Gemcitabine in Treating Women Who Are Undergoing Surgery for Early Breast Cancer
Sponsor:
Cambridge University Hospitals NHS Foundation Trust
Organization:
National Cancer Institute NCI
Organization Data
Organization:
National Cancer Institute NCI
Class:
NIH
Study ID:
CRUK-neo-tAnGo
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Cambridge University Hospitals NHS Foundation Trust
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None